Vitamin K Industry - Regional Synopsis
North America Market Statistics
North America in vitamin K market is estimated to capture around 42% revenue share by the end of 2036. The growth of the region is attributed to the presence of prominent vitamin K product manufacturers, the increasing elderly population, rising awareness of the significance of nutritional benefits, and enhanced investments in the research and development activities of Vitamin K supplements. Additionally, a significant demand for vitamin K1 injectables owing to the rising prevalence of chronic disorders such as neonatal bleeding, cancer diabetes, regulate blood sugar and osteoporosis are expected to expand. Thereby, fueling the market growth in the region during the forecast period i.e., 2024-2036.
The U.S. market is experiencing considerable expansion as a result of increased demand for food supplements, the existence of advanced healthcare amenities a growing number of vitamin K-related illnesses, and increased innovation in product development. Furthermore, the growing awareness of health and well-being in the country is also contributing to the ever-growing need for vitamin K additives. Research has demonstrated significant advantages to prevent osteoporosis, enhancing cardiovascular health, and reducing the risk of cancer. According to a publication in 2023, by Bone Health and Osteoporosis Foundation, approximately 10 million people in the U.S. are affected by osteoporosis, while an additional 44 million individuals have low bone density and are at a high risk of bone fractures.
The vitamin K market in Canada is anticipated to expand at a substantial growth rate owing to the rapid rise in chronic diseases, sedentary lifestyles, unhealthy eating habits, and the growing presence of hospitals and pharmaceutical industry players by 2036. In addition, innovative delivery systems and consumer preferences together with coagulation disorders, which disrupt blood clotting, and the CDC's blood disorder prevention programs are also surging need for vitamin K therapies. Key players such as DSM, Lonza, and CSPC Pharmaceutical Group are playing a significant role in dominating the global vitamin market, contributing to the market's growth and development.
APAC Market Analysis
Asia Pacific in vitamin K market is set to account for around 35% revenue share by 2036. The main factors contributing to the growth of the market in this region are increasing awareness among individuals about health issues and the rising population experiencing vitamin deficiencies. Moreover, due to growing health concerns, there is an expanding need for nutritional supplements, including vitamin K. This trend positions the APAC market as a key growth hub for companies operating in the vitamin K sector. Countries such as India, China, and Japan contribute to the region's market expansion thus, leading to a higher demand for vitamin K products in the region.
The vitamin K market in India is expected to grow at a steady pace owing to numerous market opportunities, such as an aging population, rising health concerns, and an increasing number of patients suffering from vitamin K deficiency. Various pharmaceutical products such as vitamin K injections and creams are also available in India, with suppliers and manufacturers operating from different areas across the country. The availability of vitamin K-rich foods, and the regulatory landscape are key factors shaping the vitamin K market in this country.
China market is driven by the quickly increasing demand from end-users like ultra-premium infant formula, dietary supplements, and medical foods. The country is predicted to hold a sizable share of the vitamin K market and emerge as a global leader. China's healthcare product market, including vitamins and health supplements, has seen increased consumption, particularly driven by the aging population. Moreover, rising healthcare expenditure and consumers' increased focus on health and wellness are anticipated to catalyze the country's market growth in the coming years.
Japan has been actively involved in R&D related to vitamin K. For instance, the Tohoku University School of Medicine has newly discovered that vitamin K efficiently inhibits ferroptosis (lipid oxidation-dependent cell death), in addition to also identifying FSP1 as an enzyme that reduces vitamin K, which had been a mystery for 50 years. It is estimated as a key proponent for treating diseases associated with ferroptosis. Thus, the country's focus on the introduction of new products demonstrates a proactive approach to public health, in turn, driving the vitamin K market growth.
